CCM
IMVT icon

Cinctive Capital Management’s Immunovant IMVT Stock Holding History

Cinctive Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
+34,435
New +$1.05M 0.05% 299
2024
Q2 		– Sell
-31,730
Closed -$1.03M – 462
2024
Q1 		$1.03M Sell
31,730
-5,111
-14% -$186K 0.05% 286
2023
Q4 		$1.55M Buy
+36,841
New +$1.36M 0.1% 206

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cinctive Capital Management's IMVT Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in Immunovant (IMVT) in Q2 2026: 34,435 shares worth $1.33M. The stake represents 0.05% of the portfolio and ranks #299 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in IMVT as recently as Q1 2024.

Cinctive Capital Management first reported a position in IMVT in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.55M in Q4 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Cinctive Capital Management held 34,435 shares of Immunovant worth $1.33M as of Q2 2026.
  • Immunovant was a new Cinctive Capital Management position in Q2 2026.
  • Immunovant made up 0.05% of Cinctive Capital Management's portfolio in Q2 2026, its #299 holding.
  • Cinctive Capital Management first reported a position in Immunovant in Q4 2023 and has held it in 3 quarters since.
  • Cinctive Capital Management's Immunovant position peaked at $1.55M in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.